Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14840-3 Trypanosoma sp Prid CSF Pt Nom Wet preparation &nbsp; ACTIVE Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14840-3 &nbsp; Wet preparation &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Trypanos CSF Wet Prep &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Cerebral spinal fluid; Cerebrospinal Fl; Chagas disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Prep; Random; Sleeping sickness; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Trypanosomiasis; Trypanosomosis; Trypanosomosis (Tse-Tse borne); Wet mount; Wet prep 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; 0
14841-1 Observation Prid XXX Pt Nom Iron hematoxylin stain &nbsp; ACTIVE Microscopic observation [Identifier] in Specimen by Iron hematoxylin stain &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14841-1 &nbsp; Iron hematoxylin stain &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 IH Stn Spec &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ID; Identity or presence; IH Stn; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified 2.78 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.78: COMPONENT: Updated to seperate the component from the method; 0
14842-9 Observation Prid XXX Pt Nom Kinyoun iron hematoxylin stain &nbsp; ACTIVE Microscopic observation [Identifier] in Specimen by Kinyoun iron hematoxylin stain &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14842-9 &nbsp; Kinyoun iron hematoxylin stain &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Kinyoun IH Stn Spec &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ID; Identity or presence; IH Stn; Infectious Disease; InfectiousDisease; Kinyoun IH Stn; Kinyoun-hematoxylin stain; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified 2.78 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.78: COMPONENT: Updated to seperate the component from the method; 0
14843-7 6-Monoacetylmorphine PrThr Gast fld Pt Ord &nbsp; &nbsp; ACTIVE 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14843-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 6MAM Gast Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14844-5 6-Monoacetylmorphine PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14844-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 6MAM SerPl Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14845-2 6-Monoacetylmorphine ACnc Urine Pt Ord &nbsp; &nbsp; DEPRECATED Deprecated Monoacetylmorphine [Presence] in Urine &nbsp; DEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14845-2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 Deprecated 6MAM Ur Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Arbitrary Concentration; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; Ql; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.4 1.0k &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14846-0 N-acetylprocainamide SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE N-acetylprocainamide [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14846-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 NAPA SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Acecainide; Acetylprocanam; DRUG/TOXICOLOGY; Drugs; Level; NAPA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14847-8 Neutrophils/Leukocytes NFr Pericard fld Pt Qn Manual count &nbsp; ACTIVE Neutrophils/Leukocytes in Pericardial fluid by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14847-8 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Neutrophils NFr Pcar Manual &nbsp; &nbsp; &nbsp; Y &nbsp; Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Pcar; Percent; Pericardial fluid; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
14848-6 Neutrophils/Leukocytes NFr Plr fld Pt Qn Manual count &nbsp; ACTIVE Neutrophils/Leukocytes in Pleural fluid by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14848-6 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Neutrophils NFr Plr Manual &nbsp; &nbsp; &nbsp; Y &nbsp; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Percent; Pleural; Pleural fluid; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
14849-4 Nitrazepam SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Nitrazepam [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14849-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Nitrazepam SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Alodorm; APODORM; AREM; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; Imeson; Insoma; Ipersed; Level; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somnibel n; Somniper; Somnite; SR; Substance concentration; Surem 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
1485-2 Gastrin^15M post 0.2 U/kg secretin MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1485-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 15M p 0.2 U/kg SCT SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 15M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome 2.34 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
14850-2 Nitrazepam SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Nitrazepam [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14850-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Nitrazepam Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Alodorm; APODORM; AREM; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; Imeson; Insoma; Ipersed; Level; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; Somnibel n; Somniper; Somnite; Substance concentration; Surem; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14851-0 Norclozapine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Norclozapine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14851-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Norclozapine SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Clozapine metabolite; Desmethylclozapine; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14852-8 Norepinephrine SCnc Plas Pt Qn &nbsp; &nbsp; ACTIVE Norepinephrine [Moles/volume] in Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14852-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Norepineph Plas-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14853-6 Norepinephrine SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Norepinephrine [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14853-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Norepineph Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14854-4 Norepinephrine SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Norepinephrine [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14854-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Norepineph 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/(24.h) &nbsp; &nbsp; &nbsp; 0
14855-1 Norfluoxetine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Norfluoxetine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14855-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Norfluoxetine SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; (S)-Norfluoxetine; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; Level; Norfluoxetin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Seproxetine; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14856-9 Nortriptyline SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Nortriptyline [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14856-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Nortrip SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; Level; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14857-7 Leukocytes other/Leukocytes NFr Pericard fld Pt Qn Manual count &nbsp; ACTIVE Leukocytes other/Leukocytes in Pericardial fluid by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14857-7 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 WBC Other NFr Pcar Manual &nbsp; &nbsp; &nbsp; Y &nbsp; Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; PCAR; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBC Other; WBCs; White blood cell; White blood cells 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
14858-5 Leukocytes other/Leukocytes NFr Plr fld Pt Qn Manual count &nbsp; ACTIVE Leukocytes other/Leukocytes in Pleural fluid by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14858-5 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 WBC Other NFr Plr Manual &nbsp; &nbsp; &nbsp; Y &nbsp; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
14859-3 Leukocytes other/Leukocytes NFr Periton fld Pt Qn Manual count &nbsp; ACTIVE Leukocytes other/Leukocytes in Peritoneal fluid by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14859-3 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 WBC Other NFr Prt Manual &nbsp; &nbsp; &nbsp; Y &nbsp; Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBC Other; WBCs; White blood cell; White blood cells 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
1486-0 Gastrin^20M post 0.2 U/kg secretin MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1486-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 20M p 0.2 U/kg SCT SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 20M p 0.2 U/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome 2.34 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
14860-1 Leukocytes other/Leukocytes NFr Synv fld Pt Qn Manual count &nbsp; ACTIVE Leukocytes other/Leukocytes in Synovial fluid by Manual count &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14860-1 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 WBC Other NFr Snv Manual &nbsp; &nbsp; &nbsp; Y &nbsp; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
14861-9 Oxalate PrThr Calculus Pt Ord &nbsp; &nbsp; ACTIVE Oxalate [Presence] in Stone &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14861-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Oxalate Stone Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Calc; Calculi; Chemistry; Ethanedioate; Ethanedioic acid; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Oxal; Oxalic acid; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14862-7 Oxalate SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Oxalate [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/d &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14862-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Oxalate 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; Ethanedioate; Ethanedioic acid; Kidney; Nephrology; Oxal; Oxalic acid; QNT; Quan; Quant; Quantitative; Renal; sRate; Substance Rate; UA; UniversalLabOrders; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/(24.h) &nbsp; &nbsp; &nbsp; 0
108,248 results found